×
About 1,073 results

ALLMedicine™ Neonatal Jaundice Center

Research & Reviews  351 results

Vitamin K
https://emedicine.medscape.com/article/2088738-overview

Jun 15th, 2022 - Reference Range Vitamin K is an essential, lipid-soluble vitamin that plays a vital role in the production of coagulation proteins. The reference range of vitamin K is 0.2-3.2 ng/mL, but impaired blood clotting has been associated with levels belo...

Vitamin K
http://emedicine.medscape.com/article/2088738-overview

Jun 15th, 2022 - Reference Range Vitamin K is an essential, lipid-soluble vitamin that plays a vital role in the production of coagulation proteins. The reference range of vitamin K is 0.2-3.2 ng/mL, but impaired blood clotting has been associated with levels belo...

Vitamin K
https://emedicine.medscape.com/article/2088738-print

Jun 15th, 2022 - Vitamin K is an essential, lipid-soluble vitamin that plays a vital role in the production of coagulation proteins. The reference range of vitamin K is 0.2-3.2 ng/mL, but impaired blood clotting has been associated with levels below 0.5 ng/mL by o...

see more →

Guidelines  2 results

Committee Opinion No. 684: Delayed Umbilical Cord Clamping After Birth.
https://doi.org/10.1097/AOG.0000000000001860
Obstetrics and Gynecology;

Dec 22nd, 2016 - Delayed umbilical cord clamping appears to be beneficial for term and preterm infants. In term infants, delayed umbilical cord clamping increases hemoglobin levels at birth and improves iron stores in the first several months of life, which may ha...

Active management of the third stage of labour: prevention and treatment of postpartum ...
https://doi.org/10.1016/S1701-2163(16)34329-8
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Leduc D, Senikas V et. al.

Nov 28th, 2009 - To review the clinical aspects of postpartum hemorrhage (PPH) and provide guidelines to assist clinicians in the prevention and management of PPH. These guidelines are an update from the previous Society of Obstetricians and Gynaecologists of Cana...

see more →

Drugs  16 results see all →

Clinicaltrials.gov  42 results

Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population
https://clinicaltrials.gov/ct2/show/NCT05365399

May 9th, 2022 - The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara. The specific objectives for this study are: To evaluate the correlation between bilirubi...

Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications
https://clinicaltrials.gov/ct2/show/NCT05365984

May 9th, 2022 - The eligible newborns will be randomized into two groups: the study group (innovative strategy) and the controlled group (traditional strategy). The innovative strategy included the ETCOc measurement in the risk evaluating process and the Internet...

Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm
https://clinicaltrials.gov/ct2/show/NCT05121311

May 3rd, 2022 - Neonatal jaundice is common and mostly transient without need for intervention. To identify infants at risk of bilirubin toxicity, bilirubin is measured several times after birth and before discharge home. As the peak bilirubin concentrations are ...

The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia
https://clinicaltrials.gov/ct2/show/NCT03876678

Apr 13th, 2022 - Hyperbilirubinemia is one of the common diseases in neonates. According to the literature, the incidence of neonatal jaundice is around 60~70% in Western countries, and even higher among newborns of Asian ethnicity. There are many causes of neonat...

Home Based Phototherapy for Neonatal Jaundice
https://clinicaltrials.gov/ct2/show/NCT03933423

Mar 31st, 2022 - Bangladesh like other low and middle-income countries has a high burden of hyperbilirubinemia induced neonatal morbidity and mortality. Approximately 60%-80% of newborns develop neonatal jaundice and 18% of infants are at risk for adverse outcomes...

see more →

News  18 results

Neonatal Wearable Device Monitors Jaundice in Real Time
https://www.medscape.com/viewarticle/947137

Mar 10th, 2021 - (Reuters Health) - Japanese researchers have developed a small, light, wearable device to measure jaundice and other vital signs in newborns, according to a new report. More than 80% of neonates develop jaundice, but continuous monitoring systems ...

Why Biliary Atresia Demands Our Respect
https://www.staging.medscape.com/viewarticle/935660

Aug 19th, 2020 - As I listened to our fellow present the case of a 5-month-old infant referred for evaluation of persistent jaundice, painful memories of several similar cases flashed by, causing me to ask, "Is this another late diagnosis of biliary atresia?" This...

FDA Panel Urges Rejection of Hyperbilirubinemia Drug for Newborns
https://www.medscape.com/viewarticle/896251

May 5th, 2018 - Federal advisers dealt a setback to the developers of the experimental medicine stannsoporfin for newborns who cannot quickly clear bilirubin and thus risk developing jaundice, by a 21-3 vote recommending rejection of manufacturer Mallinckrodt's a...

FDA Staff: Neonatal Jaundice Drug Effective, But Safety Uncertain
https://www.medpagetoday.com/pediatrics/generalpediatrics/72646

May 2nd, 2018 - WASHINGTON -- Just one dose of a drug called stannsoporfin significantly reduced bilirubin levels in newborns with severe hyperbilirubinemia, but at the potential cost of long-term neurological risk, according to an FDA briefing document prepared ...

Low-cost, Handheld Device Reliably Detects Neonatal Jaundice
https://www.medscape.com/viewarticle/890035

Dec 14th, 2017 - NEW YORK (Reuters Health) – Total serum bilirubin (TSB) levels measured with a battery-powered handheld device reliably detected neonatal jaundice in a small pilot study in Malawi, researchers say. "Jaundice affects more than half of newborns, and...

see more →